Haoran Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Haoran Wang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Chao Li
Department of Orthopaedic Surgery the Hebei Medical University Third Hospital Key Laboratory of Biomechanics of Hebei Province Orthopaedic Research Institution of Hebei Province NHC Key Laboratory of Intelligent Orthopaedic Equipment No.139 Ziqiang Road Shijiazhuang 050051 P. R. China
1 shared publicationJuan Wang
Department of Orthopaedics Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine 197 Ruijin 2nd Road Shanghai 200025 P. R. China
1 shared publicationMo Zhang
Department of Orthopaedic Surgery the Hebei Medical University Third Hospital Key Laboratory of Biomechanics of Hebei Province Orthopaedic Research Institution of Hebei Province NHC Key Laboratory of Intelligent Orthopaedic Equipment No.139 Ziqiang Road Shijiazhuang 050051 P. R. China
1 shared publication- Wei Chen
Trauma Emergency Center, the Third Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China
1 shared publication - Wenguo Cui
Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Department of Orthopaedics Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
1 shared publication - Yawei Du
Department of Orthopaedics Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine 197 Ruijin 2nd Road Shanghai 200025 P. R. China
1 shared publication
Latest Publications
- Top Cited Papers
- 14 May 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (30) , e2402968
Activating Macrophage Continual Efferocytosis via Microenvironment Biomimetic Short Fibers for Reversing Inflammation in Bone Repair
Efferocytosis‐mediated inflammatory reversal plays a crucial role in bone repairing process. However, in refractory bone defects, the macrophage continual efferocytosis may be suppressed due to the disrupted microenvironment homeostasis, particularly the loss of apoptotic signals and overactivation of intracellular oxidative stress. In this study, a polydopamine‐coated short fiber matrix containing biomimetic “apoptotic signals” to reconstruct the microenvironment and reactivate macrophage continual efferocytosis for inflammatory reversal and bone defect repair is presented. The “apoptotic signals” (AM/CeO2) are prepared using CeO2 nanoenzymes with apoptotic neutrophil membrane coating for macrophage recognition and oxidative stress regulation. Additionally, a short fiber “biomimetic matrix” is utilized for loading AM/CeO2 signals via abundant adhesion sites involving π–π stacking and hydrogen bonding interactions. Ultimately, the implantable apoptosis‐mimetic nanoenzyme/short‐fiber matrixes (PFS@AM/CeO2), integrating apoptotic signals and biomimetic matrixes, are constructed to facilitate inflammatory reversal and reestablish the pro‐efferocytosis microenvironment. In vitro and in vivo data indicate that the microenvironment biomimetic short fibers can activate macrophage continual efferocytosis, leading to the suppression of overactivated inflammation. The enhanced repair of rat femoral defect further demonstrates the osteogenic potential of the pro‐efferocytosis strategy. It is believed that the regulation of macrophage efferocytosis through microenvironment biomimetic materials can provide a new perspective for tissue repair.
- 14 May 2024
- Published by Wiley in Advanced Materials
- Vol. 36 (30) , e2402968
Top Cited PapersActivating Macrophage Continual Efferocytosis via Microenvironment Biomimetic Short Fibers for Reversing Inflammation in Bone Repair
Efferocytosis‐mediated inflammatory reversal plays a crucial role in bone repairing process. However, in refractory bone defects, the macrophage continual efferocytosis may be suppressed due to the disrupted microenvironment homeostasis, particularly the loss of apoptotic signals and overactivation of intracellular oxidative stress. In this study, a polydopamine‐coated short fiber matrix containing biomimetic “apoptotic signals” to reconstruct the microenvironment and reactivate macrophage continual efferocytosis for inflammatory reversal and bone defect repair is presented. The “apoptotic signals” (AM/CeO2) are prepared using CeO2 nanoenzymes with apoptotic neutrophil membrane coating for macrophage recognition and oxidative stress regulation. Additionally, a short fiber “biomimetic matrix” is utilized for loading AM/CeO2 signals via abundant adhesion sites involving π–π stacking and hydrogen bonding interactions. Ultimately, the implantable apoptosis‐mimetic nanoenzyme/short‐fiber matrixes (PFS@AM/CeO2), integrating apoptotic signals and biomimetic matrixes, are constructed to facilitate inflammatory reversal and reestablish the pro‐efferocytosis microenvironment. In vitro and in vivo data indicate that the microenvironment biomimetic short fibers can activate macrophage continual efferocytosis, leading to the suppression of overactivated inflammation. The enhanced repair of rat femoral defect further demonstrates the osteogenic potential of the pro‐efferocytosis strategy. It is believed that the regulation of macrophage efferocytosis through microenvironment biomimetic materials can provide a new perspective for tissue repair.